The gene expression of human cytomegalovirus (HCMV) is temporally regulated by host cell and viral proteins during the infection cycle (9, 20, 59, 64, 65) . The immediate-early (IE) genes are the first HCMV genes expressed after infection and produce transcriptional regulatory proteins that control subsequent viral gene expression (4, 11, 51, 53, (56) (57) (58) 60) . The mechanisms of transcriptional regulation by these proteins are not completely understood but may be mediated by direct binding of DNA or protein-protein interactions with cellular transcription factors.
The predominant IE proteins originate from two contiguous regions of abundant IE expression, historically termed IE region 1 (IE-1/UL123) (5, 55, 57) and IE region 2 (IE-2/UL122) (5, 55, 58) . Since the major IE promoter (MIEP) directs the expression of both regions, IE-1 and IE-2 constitute the major IE gene. However, within the IE2 region, an internal late promoter directs the expression of an mRNA encoding a 40-kDa protein (LAO) with a reading frame that overlaps those for other proteins encoded in this region (52, 55) . Alternative splicing and polyadenylation events generate mRNAs that code for variant isoforms of an IE protein (55, 57, 58) . The three predominant IE isoforms are phosphoproteins (15) with apparent molecular masses of 86 kDa (IE86), 72 kDa (IE72), and 55 kDa (IE55). IE72 has the same N terminus as IE86 and IE55, while IE86 and IE55 have identical amino acid sequences except for a 154-aminoacid deletion between amino acid residues 365 and 519 in IE86 ( Fig. 1) (55, 57, 58) . Functionally, the IE isoforms are all capable of transactivating heterologous promoters (1, 11, 14, 17, 19, 56, 61, 63) , while IE72 and IE86 together demonstrate strong synergistic activity (11, 14, 17, 56, 60, 61, 63) . The IE proteins also autoregulate their own promoter (1, 8, 16, 32, 43, 49, 56) . While IE86 represses MIEP expression through a DNA sequence known as the cis repression signal (crs) element (-14 to +1) (7, 29, 41) , IE72 (8, 49) and IE55 (1) transactivate this promoter. Levels of these isoforms within a cell are critical for the activity of the MIEP and may be the ultimate determinant for the viral permissiveness of a cell.
The IE isoform proteins contain amino acid sequences with characteristics similar to those of other transcription factors (2, 24, 34, 35, 47, 62) . Some putative motifs include three amphipathic helices at the N terminus of all the isoforms, single zinc finger motifs in IE86 and IE72, a leucine zipper in the IE72 protein, and a leucine-rich region in the IE86 protein (Fig. 1) . Each isoform also contains two nuclear localization signals, which have been previously described (42) . Sequences within exon 3 and the C terminus of IE86 and IE55 were found to be critical for promoter activation (16, 32, 43, 56) . Domains responsible for negative regulation by IE86 were localized to the C terminus (29, 41, 56) .
The mechanism of IE86 autorepression of the MIEP is unclear. Other viral models of autorepression have suggested that either protein-protein interactions or direct binding of a cis-responsive sequence may mediate this process (18, 22, 36, 44, 45) . Recently, the IE86 protein was shown to bind the crs element (25) . A truncated portion of this protein closely equivalent to the LA0 protein was also able to bind this element and induce repression in cell-free nuclear extracts (30) . These observations, in combination with the inability of the crs element to function when placed 5' to the TATA box (7) Mobility shift assay. The mobility shift assay was performed essentially as described previously (13) Following addition of the protein extract, 3 ml of Econofluor 2 (New England Nuclear, Boston, Mass.) was added. At increasing time intervals, the reaction was monitored by scintillation counting, and the linear range was determined, at which point the fold induction was calculated. Each experiment was repeated at least three times, from which an average and standard deviation were determined.
DNase I protection analysis. The DNase I protection analysis was performed essentially as described previously (12) . Briefly, the assay buffer contained 25 mM Tris-HCl (pH 8.0), 0.5 mM dithiothreitol, 0.5 mM EDTA, 6.25 mM MgCl2, 0.2 p,g of poly(dG)-poly(DC), 10% glycerol, and cold competitor oligonucleotides where indicated, in a total volume of 25 ,ul.
Recombinant IE86, TBP, or bovine serum albumin (BSA) was incubated for 2 min in assay buffer prior to the addition of probe which had been labeled with [a-32P]ATP on either the top-or bottom-strand oligonucleotide before annealing with the complementary cold oligonucleotide. After a further 10-min incubation, 1 U of DNase I was added, and the incubation was continued for 90 s, at which time the reaction was stopped with the addition of 100 PIu of 200 mM NaCl-1% SDS-20 mM EDTA-50 p,g of tRNA per ml-2.5 p,g of proteinase K per ml. Following a further 10-min incubation at 37°C, the samples were extracted with phenol and chloroform before being loaded on a 12% denaturing polyacrylamide gel. In the experiments with both IE86 and TBP, either IE86 or TBP was allowed to bind the probe for 5 min prior to the addition of the remaining protein, at which time the incubation was continued for 10 min before addition of the DNase I. Subsequently, the gel was dried and the protection patterns were visualized by autoradiography.
Oligonucleotides. The following oligonucleotides were synthesized on a Gene Assembler Plus (Pharmacia LKB): -35 to +4 MIEP, (top) 5'-AGCTTGAGGTCTATATAAGCA GAGCTCG'Tfl'l'AGTGAACCGTCAG-3' and (bottom) 5 GGGCTCT-lCGA-3'. The oligonucleotides were subjected to denaturing preparative PAGE with 12% polyacrylamide. The oligonucleotides were visualized by low-power UV (210 nm) shadowing on photocopying paper, and full-length product was excised from the gel and electroeluted into lx TBE (90 mM Tris-borate and 2 mM EDTA) buffer.
RESULTS
Binding of EE86 to the crs element. To examine the ability of IE86 to bind to the crs element, the gene encoding IE86 was expressed in E. coli under the control of an IPTGinducible promoter. To facilitate purification, a short linker sequence encoding six histidine residues was cloned onto the 5' end of the IE86 cDNA (Fig. 2B) . Under nondenaturing conditions, IE86 was purified to approximately 90% homogeneity by nickel chelate chromatography ( Fig. 2A, lane 1) . A similar methodology using denaturing conditions has been described previously (25) . To identify the domain responsible for contacting DNA, a variety of mutant IE86 proteins were constructed ( Fig. 2B) and purified ( Fig. 2A, lanes 2 to   5 ). In addition, the gene encoding IE55 was expressed and purified to a similar homogeneity from E. coli (data not shown). Initially, binding of IE86 to a labeled probe whose sequence corresponded to that of the MIEP from -35 to +4 was examined in a mobility shift assay (Fig. 3A, lane 5) .
Although highly pure IE86 protein was used, a monoclonal antibody that recognized an epitope encoded within exon 2/3 was used to supershift the IE86 nucleoprotein complex to show that IE86 was indeed part of this complex (Fig. 3A,  lane 7) . A supershift was not observed with a monoclonal antibody directed against the gpl20 envelope protein of human immunodeficiency virus (Fig. 3A, lane 6) . The probe was not shifted with either antibody in the absence of IE86 (data not shown). In addition, a second probe whose sequence corresponded to that of the MIEP from -35 to +18 was also used in some of the mobility shift experiments. Binding of IE86 to this probe was identical to that of the previous probe (Fig. 3B, lane 2) .
To show the specificity of binding, various competition experiments were performed with a 50-fold excess of a variety of different unlabeled probes. Competition was initially performed with a cold excess of the -35/+4 and -35/+18 MIEP probes. Under these conditions, no nucleoprotein complexes were observed between either the shorter or the longer labeled probe and IE86 (Fig. 3A, (Fig. 3A, lane 3) . Therefore, the putative zinc finger is important for DNA binding. Examination of the literature, however, revealed that deletion of the acidic C-terminal domain of IE86 from amino acids 542 to 579 eliminated the ability of IE86 to negatively regulate the MIEP in vivo (43) . To determine whether this mutation abrogated the ability of IE86 to bind DNA, we analyzed the IE86AC2 mutant (Fig. 2) in a mobility shift assay. Nucleoprotein complex formation was not detected with this mutant protein and the crs probe (Fig. 3B,  lane 7) . From these data, the region of IE86 responsible for contacting DNA would appear to be more extensive and not restricted to the putative zinc finger domain. Alternatively, the C-terminal domain could be solely responsible for mediating the binding of IE86 to DNA, and disruption of such an important structural component as a zinc finger may have caused more extensive perturbations in the overall configuration of the protein that would contribute to its nonfunctionality. Therefore, the naturally occurring IESS isoform of the IE86 protein described above, which lacks the putative zinc finger but has an intact C-terminal acidic region, was examined for its ability to bind DNA. As shown in Fig. 3B , lane 10, no nucleoprotein complex formation was observed between IESS and probe. Therefore, the C-terminal acidic domain cannot bind DNA in the absence of the putative zinc finger and/or possibly the leucine-rich domain. Thus, the inability of IESS to repress transcription from the MIEP in vivo (1) is probably a direct result of the protein's inability to bind DNA.
In vivo activation but not repression by mutant IE86. As described above, IE86 mZn was unable to bind the probe in a mobility shift assay. To examine whether this was the result of a specific knockout of the putative zinc finger and not of a general disruption of the structure of the protein, we tested the ability of this mutant to function in vivo in a cell line permissive for HCMV infection. All of the effector plasmids shown in Fig. 4 produced proteins without the six-histidine tag at their N terminus. Expression of the same proteins with six-histidine tags yielded no difference in their ability to transactivate or repress transcription (data not shown). In the first experiment, shown in Fig. 4A , a construct containing the MIEP, including the upstream enhancer and modulator sequences driving the expression of the CAT gene, was used as the target reporter plasmid to detect transactivation or repressive functions of the HCMV IE86 protein. IE86 specifically repressed transcription of the MIEP(-1145/+112)CAT reporter plasmid by 0.4-fold (Fig.  4A) . Cotransfection of more IE86 did not result in further repression (data not shown). Greater repression was observed when IE86 was transfected in the presence of IE72, which increased the basal level of promoter activity (data not shown). In contrast, the IE86 protein containing the knockout of the putative zinc finger was not only unable to repress transcription but stimulated it by approximately sixfold (Fig.  4A) .
In the second experiment, shown in Fig. 4B , the function of wild-type and mutant IE86 proteins was examined with the construct containing the mutated crs element [pMIEP (mcrs)CAT]. The wild-type and zinc finger mutant IE86 proteins stimulated this reporter construct to a similar degree (Fig. 4B) . In this experiment, the fold induction observed for both proteins was similar to that obtained with the MIEP(-1145/+112)CAT reporter plasmid when stimulated with IE86 mZn (Fig. 4, compare A and B) . The IE86 protein has previously been shown to require both its N terminus and an intact C-terminal acidic domain to be competent to transactivate both homologous and heterologous promoters (16, 43, 56 Fig. 5 . In lanes 2 and 3 (top strand) and lanes 7 and 8 (bottom strand), increasing concentrations of IE86 were used. The concentration required to give complete protection was approximately 250 nM (Fig. 5, lanes 3 and 8) , similar to that used in the mobility shift assay and approximately 10-fold over that of the probe. A similar concentration of BSA added as control gave no protection (Fig. 5, lanes 1 and 6) . To show that this protection was specific, competition analyses were performed with a 50-fold excess of cold probe (Fig. 5, lanes  4 and 9) and -35/+4 m2crs MIEP probe as a nonspecific competitor (Fig. 5, lanes 5 and 10) . The specific probe competed for binding to IE86, since it eliminated the protection of the labeled probes, whereas protection persisted in the presence of the m2crs nonspecific probe. The extent of protection observed on the top strand was between nucleotide positions -18 and + 10 and on the bottom strand was between positions -24 and +3.
Since the footprint of IE86 overlaps the TATA box, especially on the bottom strand, we hypothesized that IE86 binding might prevent the interaction of TBP with the TATA box. To test this hypothesis, we first investigated the binding of TBP alone to the -35/+18 MIEP probe. We observed two areas of protection with this probe between -31 and -15, corresponding to protection of the TATA box, and between -20 and -5 (data not shown). Closer examination of the latter revealed the sequence 'T'l'AGT between -12 and -7. This sequence was sufficiently similar to a TATA box to behave as a cryptic binding site for TBP. Since this sequence constitutes a large portion of the crs element, this probe could not be used to test the hypothesis that IE86 might be able to abrogate the binding of TBP to the TATA box. Therefore, a mutation in this sequence was introduced which changed the T at position -11 to a C (T'TAGT to TCTAGT) in the context of the -35/+18 MIEP probe (to generate -35/+18 m3crs MIEP), eliminating this cryptic site. Since this substitution was in the crs element, we first determined whether the binding of IE86 to the -35/+18 m3crs MIEP probe was different from that of the wild-type probe. These data are shown in Fig. 6A . Identical protection of this probe was observed with the same concentration of IE86 that yielded complete protection of the wild-type probe (Fig. 6A,  lanes 3 and 7) . The probe was not protected in the presence of BSA (Fig. 6A, lanes 1 and 5) or when a 50-fold excess of cold probe was added (Fig. 6A, lanes 4 and 8) , indicating that the protection was specific.
Incubation of the -35/+18 m3crs probe with 50 nM TBP followed by DNase I digestion provided approximately 15 to 20 bp of protection around the TATA box (Fig. 6B, lanes 2  and 6) . The result of increasing the concentration of IE86 following incubation of the probe with 50 nM TBP is shown in Fig. 6B , lanes 3 and 4 (top strand) and lanes 7 and 8 (bottom strand). For complete protection of the top strand in the presence of TBP, at least 500 nM IE86 was routinely required. The bottom strand normally required 250 nM IE86 for complete protection of the crs element while maintaining TBP protection over the TATA box. However, in some experiments, 500 nM of IE86 was required for complete protection of the crs element in the presence of TBP (data not shown). In a reciprocal experiment, increasing concentrations of TBP were added to the probe following incubation with IE86. Under these conditions, both sites could be protected simultaneously, although higher concentrations of TBP were required to show protection of the TATA box in the presence of prebound IE86 (data not shown). In addition, we also observed in these experiments and in a mobility shift assay (unpublished observations) that IE86 stabilized the binding of TBP to DNA.
To show that the simultaneous protection of both the TATA box and the crs element was specific, we repeated the experiment in Fig. 6B with the putative zinc finger mutant of IE86, which was shown above to be unable to bind DNA and yet was fully competent to act as a transcriptional activator in vivo (Fig. 4A) . Shown in Fig. 7 , lanes 2 and 6, is the protection pattern obtained in the presence of TBP alone. Addition of IE86 mZn resulted in no significant protection of the crs element even at a concentration of 1 ALM (Fig. 7, lanes  4 and 8) . In higher concentrations of IE86 or TBP were required for synchronous binding.
DISCUSSION
We have identified funcitonal domains of the IE86 protein of HCMV, which acts as a repressor of transcription by binding to a specific sequence, termed the cis repression signal (crs), located just downstream of the TATA box. We found that IE86 could not displace the binding of human TBP to the TATA box. Moreover, IE86 and TBP could bind their respective elements simultaneously, although higher concentrations of IE86 were required, suggesting that there might be steric constraints disrupting but not preventing both proteins from binding DNA synchronously.
Binding of IE86 to DNA has also been recently described by Lang and Stamminger (25) IE86-mediated repression of MIEP transcription in a HeLa cell nuclear extract with their C-terminal IE86 fusion protein. Mutation of the zinc finger in this fusion protein destroyed any ability to repress transcription. We also investigated the effect on transcription from the MIEP by an IE86 protein containing a similar mutation in the putative zinc finger in vivo. Mutation of this amino acid motif converted the function of the IE86 protein from a repressor to an activator of MIEP transcription. This experiment not only demonstrates the integrity of this mutant but also shows the importance of the putative zinc finger in mediating repression in vivo. In addition to the putative zinc finger, we also observed that the acidic C-terminal region was important for binding the crs element in vitro, explaining the inability of this mutant to function in vivo (43) . Therefore, it remains to be determined which domain within this region of IE86 contacts DNA and whether this occurs through a previously defined protein fold, such as a zinc finger, or via a distinct protein motif.
The footprint we observed for IE86 in the DNase I protection experiments was identical to that obtained by Lang and Stamminger with their IE86 (25) . Since the IE86 footprint overlaps sequences which have been shown previously to be protected by TBP (6, 26, 40, 54) , we examined the possibility that binding of IE86 and TBP to their respective elements might be mutually exclusive. The footprint obtained for TBP alone was similar to that described previously (6, 26, 40, 54 (22, 45) . Therefore, the function of IE86 closely parallels that of ICP4. In addition, the papillomavirus E2 gene product and the adenovirus Ela protein have also been shown to both transactivate and repress transcription (3, 18, 28, 33) . In contrast to IE86, the E2 product, although requiring a specific sequence element, will function in cis in an orientation-and position-independent manner. Interestingly, the E2 gene product, in addition to negatively autoregulating expression of its own promoter (18) , has been shown to repress transcription of the E6 and E7 gene products through similar sequence motifs (46) . This raises the intriguing question of whether IE86 might perform a parallel function in HCMV. A search of the HCMV genome for sequences identical to the crs element (taken as -14 to +1) proved negative (7) . However, the sequence that was used to search the HCMV genome may not have been the minimum sequence necessary to allow binding of IE86. Moreover, some mutations, such as that present in the -35/+18 (m3crs) MIEP sequence, still permitted binding. Further analysis of the sequencebinding specificity of IE86 is required to determine whether there are other sites in the HCMV genome at which IE86 could influence transcription.
Since the MIEP drives the expression of a single precursor mRNA, the virus has the ability to "cassette" various protein domains together by differential splicing of the precursor. This results in the formation of IE86, IE55, and IE72 as well as several uncharacterized proteins (55, 56) . In addition, differential splicing also provides the virus with a further control mechanism by which it can channel the processing of the precursor from one mRNA transcript (encoding an activator) to another (encoding a repressor, for example). The ability of HCMV to cassette protein domains together is by no means unusual; indeed, many other viruses utilize a similar editing procedure. For example, the E2 gene of papillomavirus undergoes differential splicing to encode two products, the 48-kDa transactivator and the 28-kDa repressor (23, 33) . Similarly, the Ela protein exists in two isoforms as a result of differential splicing of its precursor mRNA (39) . In the longer 13s form, the activation domain is dominant over the domain responsible for mediating repression, whereas the shorter 12s form lacks part of the N-terminal domain responsible for mediating activation and therefore functions as a repressor. Interestingly, this is in contrast to IE86, in which the repressive domain is dominant over the activation domain. The results presented herein thus demonstrate some of the piquant features of the major IE proteins, especially IE86, and further emphasize their importance in regulating the transcription of the HCMV genome.
